Catalyst Funds Management Pty LTD Hutchmed (China) LTD Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 139,748 shares of HCM stock, worth $2.21 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
139,748
Previous 142,231
1.75%
Holding current value
$2.21 Million
Previous $2.05 Billion
2.55%
% of portfolio
0.55%
Previous 0.5%
Shares
2 transactions
Others Institutions Holding HCM
# of Institutions
63Shares Held
6.44MCall Options Held
9.9KPut Options Held
9.6K-
Schroder Investment Management Group London, X02.84MShares$45 Million0.05% of portfolio
-
Allianz Asset Management Gmb H Munich, 2M1MShares$15.9 Million0.02% of portfolio
-
State Street Corp Boston, MA337KShares$5.33 Million0.0% of portfolio
-
Aia Group LTD Hong Kong, K3315KShares$4.99 Million0.13% of portfolio
-
M&G PLC London, X0259KShares$4.09 Million0.03% of portfolio
About HUTCHMED (China) Ltd
- Ticker HCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 172,955,008
- Market Cap $2.73B
- Description
- HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...